These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10226868)

  • 41. A double-blind placebo-controlled study evaluating the onset of action of doxazosin gastrointestinal therapeutic system in the treatment of benign prostatic hyperplasia.
    Roehrborn CG; Prajsner A; Kirby R; Andersen M; Quinn S; Mallen S
    Eur Urol; 2005 Sep; 48(3):445-52; discussion 452. PubMed ID: 15996811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of doxazosin in systemic hypertension.
    Ames RP; Chrysant SG; Gonzalez F; Schnaper HW; Spann S; Velasquez MT
    Am J Cardiol; 1989 Jul; 64(3):203-8. PubMed ID: 2525870
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and effectiveness of replacing standard doxazosin with doxazosin in the gastrointestinal therapeutic system (GITS) formulation in elderly hypertensive patients.
    Jiménez-García R; Anegón M; Esteban J; Carrasco P; Apaolaza I; Gil A
    Int J Clin Pract; 2003 May; 57(4):267-72. PubMed ID: 12800456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol.
    Baez MA; Garg DC; Jallad NS; Weidler DJ
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):63S-67S. PubMed ID: 2939869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
    Fagan TC; Haggert BE; Liss C
    Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial.
    Searle M; Dathan R; Dean S; Christensen CC; Westheim A
    Eur J Clin Pharmacol; 1990; 39(3):299-300. PubMed ID: 2147909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of the doxazosin gastrointestinal therapeutic system for the treatment of benign prostate hyperplasia.
    Sun GH; Tsui KH; Wu TT; Chang CH; Cheng CL; Schou M
    Kaohsiung J Med Sci; 2010 Oct; 26(10):532-9. PubMed ID: 20950778
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension.
    Nechwatal W; Berger J; Blumrich W; Bouzo H; Brandl K; Braun S; Laukaitis A; Müller G; Ryba W; Schreiegg J
    Am Heart J; 1988 Dec; 116(6 Pt 2):1806-14. PubMed ID: 2904755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-blockade and thiazide treatment of hypertension. A double-blind randomized trail comparing doxazosin and hydrochlorothiazide.
    Grimm RH; Flack JM; Schoenberger JA; Gonzalez NM; Liebson PR
    Am J Hypertens; 1996 May; 9(5):445-54. PubMed ID: 8735175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Krakoff LR; Bravo EL; Tuck ML; Friedman CP
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):318S-325S. PubMed ID: 2078318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension.
    Lee SH; Park KK; Mah SY; Chung BH
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):333-7. PubMed ID: 20567256
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
    Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
    Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A single-blind study of doxazosin in the treatment of essential hypertension when added to nonresponders to angiotensin-converting enzyme inhibitor therapy.
    Englert RG; Mauersberger H
    Am Heart J; 1988 Dec; 116(6 Pt 2):1826-32. PubMed ID: 2904758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The 24-hour efficacy of a new once-daily formulation of nifedipine. Italian Nifedipine GITS Study Group.
    Zanchetti A
    Drugs; 1994; 48 Suppl 1():23-30; discussion 30-1. PubMed ID: 7533703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Doxazosin in the treatment of benign prostatic hyperplasia in normotensive patients: a multicenter study.
    Fawzy A; Braun K; Lewis GP; Gaffney M; Ice K; Dias N
    J Urol; 1995 Jul; 154(1):105-9. PubMed ID: 7539853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.